Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate canc (Q44652200)
Jump to navigation
Jump to search
scientific article published on November 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate canc |
scientific article published on November 1, 2003 |
Statements
Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer (English)
Hans Stricker
Jan Pegg
Dell Paielli
James Peabody
Mariza DePeralta-Venturina
Xueqing Xia
Steve Brown
Mei Lu
Jae Ho Kim
Svend O. Freytag
Deepak G. Pradhan
1 November 2003